Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Asıl Yazarlar: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1998
|
Benzer Materyaller
-
Monoclonal-antibody therapy in systemic vasculitis.
Yazar:: Mathieson, P, ve diğerleri
Baskı/Yayın Bilgisi: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
Yazar:: Mathieson, P, ve diğerleri
Baskı/Yayın Bilgisi: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
Yazar:: Lockwood, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Yazar:: Lockwood, C, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
Yazar:: Isaacs, J, ve diğerleri
Baskı/Yayın Bilgisi: (1993)